InvestorsHub Logo
Followers 22
Posts 1318
Boards Moderated 0
Alias Born 06/01/2013

Re: oncswatcher post# 44121

Monday, 02/27/2017 1:19:29 PM

Monday, February 27, 2017 1:19:29 PM

Post# of 50725
You may be proven correct in your opinion. However, even if the Rubicon at the university is a success and the price bumps up (this is what I think will occur also though .30 or higher is a bit optimistic based on the number of shares outstanding)

It is obvious market sentiment for DNRG is not good at the moment. This has been shown by all the missed dates.

The question is, how can the company raise the capital needed? They say they need over 3 mill this year. Wages have not been paid. They have no cash.

For a publicly traded company selling stock is one venue, loans another, or buyouts, or a lot of conventional means to gain capital needed.

For speculation only, the following are the scenerio's I see based on what I know as an investor in this company:

1. Buyout or merger - 0% - .02% chance (almost nonexistent)
2. Financial backing by a sound financial institution 20% -30%
3. Authorizing more shares to be issued, such a number to be 2 billion plus - 10%
4. A positive action such as the actual deployment of the Rubicon at the University stimulating the current shares in price. 90%-100%
5. Financing by 'less than good terms' 60%-80%
6. A plan of the coming deployment of the Rubicon at the university being successful, rising stock price, and loan by a sound financial institution 60%-80%.
7. A plan of the coming deployment of the Rubicon at the university being successful, rising stock price, and a new investor prospectus combined with a R/S 75% - 100%
8. Bankruptcy and complete closure of the company 1% -20%

We'll all get to see what happens in the next few months. This year for DNRG will indeed be interesting. Maybe as an investor I'll make some coin, maybe not.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.